Finch Therapeutics Group Inc
OTC:FNCH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Finch Therapeutics Group Inc
OTC:FNCH
|
US |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
Nouveau Monde Graphite Inc
XTSX:NOU
|
CA |
|
M
|
Marex Group PLC
NASDAQ:MRX
|
UK |
|
Orthocell Ltd
ASX:OCC
|
AU |
|
Mercury NZ Ltd
NZX:MCY
|
NZ |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
B
|
Bimobject AB
STO:BIM
|
SE |
|
Vera Bradley Inc
NASDAQ:VRA
|
US |
|
BigBear.ai Holdings Inc
NYSE:BBAI
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
OneMain Holdings Inc
NYSE:OMF
|
US |
|
Celltrion Inc
KRX:068270
|
KR |
|
LuxExperience BV
F:0FV
|
DE |
|
Sensient Technologies Corp
NYSE:SXT
|
US |
|
Catalyst Metals Ltd
ASX:CYL
|
AU |
Bankruptcy Probability
Finch Therapeutics Group Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Finch Therapeutics Group Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Finch Therapeutics Group Inc
OTC:FNCH
|
12m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Finch Therapeutics Group Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Finch Therapeutics Group Inc has no debt.
You can find a full breakdown on its Balance Sheet.
